AzurRx BioPharma, Inc. Banner Image

AzurRx BioPharma, Inc. has reached its limit for free report views

Work for AzurRx BioPharma, Inc.? Upgrade Your Profile and unlock all your annual reports.

AzurRx BioPharma, Inc.

  • Ticker AZRX
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
AzurRx BioPharma, Inc. Logo Image
  • 1-10 Employees
  • Based in Langlade, Wisconsin
AzurRx BioPharma, Inc. (NASDAQ: AZRX) is a biopharmaceutical company specializing in the research and development of non-systemic biologics for gastrointestinal disorders. The Company is focused on the development of its lead drug candidate, MS1819. AzurRx is currently conducting two Phase 2 clinical trials of MS1819: the OPTION 2 monotherapy trial and the Combination therapy trial, consistingMore of MS1819 in conjunction with porcine-derived pancreatic enzyme replacement therapy, the current standard of care. The Company is headquartered in New York, New York, with clinical operations in Hayward, California.
AzurRx BioPharma, Inc.

Most Recent Annual Report

AzurRx BioPharma, Inc. MOST RECENT 2019 Form 10K

Report Locked. AzurRx BioPharma, Inc. has reached its limit for free report views.